SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051456
Filing Date
2020-11-05
Accepted
2020-11-05 17:05:48
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avro-10q_20200930.htm   iXBRL 10-Q 2361971
2 EX-3.2 avro-ex32_90.htm EX-3.2 23530
3 EX-31.1 avro-ex311_8.htm EX-31.1 17721
4 EX-31.2 avro-ex312_6.htm EX-31.2 17793
5 EX-32.1 avro-ex321_9.htm EX-32.1 10868
  Complete submission text file 0001564590-20-051456.txt   6369945

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA avro-20200930.xsd EX-101.SCH 42919
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avro-20200930_cal.xml EX-101.CAL 29178
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avro-20200930_def.xml EX-101.DEF 96748
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20200930_lab.xml EX-101.LAB 309470
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20200930_pre.xml EX-101.PRE 222362
11 EXTRACTED XBRL INSTANCE DOCUMENT avro-10q_20200930_htm.xml XML 918928
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 201291459
SIC: 2836 Biological Products, (No Diagnostic Substances)